Nicotine therapeutic benefits: Difference between revisions
Jump to navigation
Jump to search
(adding content) |
(Added Huntington’s Disease) |
||
| Line 549: | Line 549: | ||
==HIV/AIDS== <!--T:120--> | ==HIV/AIDS== <!--T:120--> | ||
<br> | |||
==Huntington’s Disease== | |||
===2005: [https://pubmed.ncbi.nlm.nih.gov/16140176/ Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats]=== | |||
*These results clearly showed neuroprotective effect of nicotine in experimental model of HD. The clinical relevance of these findings in HD patients remains unclear and warrants further studies. | |||
*In conclusion, nicotine significantly and dose-dependently attenuated 3-NP-induced striatal lesions and behavioral deficits in rats. The protective effect of nicotine may be attributed to its ability of restoring striatal DA levels in 3-NP intoxicated rats. | |||
*[https://sci-hub.se/10.1016/j.brainresbull.2005.06.024 PDF Version] | |||
*Citation: Tariq M, Khan HA, Elfaki I, Al Deeb S, Al Moutaery K. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Brain Res Bull. 2005 Sep 30;67(1-2):161-8. doi: 10.1016/j.brainresbull.2005.06.024. PMID: 16140176. | |||
<br> | |||
==Mental Health - ADD / ADHD / Attention== <!--T:121--> | ==Mental Health - ADD / ADHD / Attention== <!--T:121--> | ||